Design and Synthesis of a Cell-Permeable, Drug-Like Small Molecule Inhibitor Targeting the Polo-Box Domain of Polo-Like Kinase 1-Reference-Cited by-同舟云学术

Design and Synthesis of a Cell-Permeable, Drug-Like Small Molecule Inhibitor Targeting the Polo-Box Domain of Polo-Like Kinase 1

Published:2014-09-11 Issue:9 Volume:9 Page:e107432
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Srinivasrao Ganipisetti,Park Jung-Eun,Kim Sungmin,Ahn Mija,Cheong Chaejoon,Nam Ky-Youb,Gunasekaran Pethaiah,Hwang Eunha,Kim Nam-Hyung,Shin Song Yub,Lee Kyung S.,Ryu Eunkyung,Bang Jeong Kyu

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. Polo-like kinases and the orchestration of cell division;FA Barr;Nat Rev Mol Cell Biol,2004

2. Getting in and out of mitosis with Polo-like kinase-1;MA Van Vugt;Oncogene,2005

3. Polo-like kinases: positive regulators of cell division from start to finish;EA Nigg;Curr Opin Cell Biol,1998

4. Polo kinase: the choreographer of the mitotic stage;DM Glover;J Cell Biol,1996

5. Polo-like kinases: a team that plays throughout mitosis;DM Glover;Genes Dev,1998

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitors of the PLK1 polo-box domain: drug design strategies and therapeutic opportunities in cancer;Expert Opinion on Drug Discovery;2023-01-01

2. Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential;Journal of Medicinal Chemistry;2022-07-25

3. Novel Macrocyclic Peptidomimetics Targeting the Polo-Box Domain of Polo-Like Kinase 1;Journal of Medicinal Chemistry;2022-01-14

4. Protein Interaction Domains and Post-Translational Modifications: Structural Features and Drug Discovery Applications;Current Medicinal Chemistry;2020-11-06

5. Peptidomimetic Polo‐Box‐Targeted Inhibitors that Engage PLK1 in Tumor Cells and Are Selective against the PLK3 Tumor Suppressor;ChemMedChem;2020-04-28